Skip to main content

CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS

Publication ,  Conference
Lancet, J; Uy, G; Cortes, J; Newell, L; Lin, T; Ritchie, E; Strickland, S; Stuart, R; Hogge, D; Solomon, S; Stone, R; Bixby, D; Kolitz, J ...
Published in: HAEMATOLOGICA
June 1, 2016

Duke Scholars

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 1, 2016

Volume

101

Start / End Page

186 / 186

Location

Copenhagen, DENMARK

Publisher

FERRATA STORTI FOUNDATION

Conference Name

21st Congress of the European-Hematology-Association

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lancet, J., Uy, G., Cortes, J., Newell, L., Lin, T., Ritchie, E., … Medeiros, B. (2016). CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS. In HAEMATOLOGICA (Vol. 101, pp. 186–186). Copenhagen, DENMARK: FERRATA STORTI FOUNDATION.
Lancet, J., G. Uy, J. Cortes, L. Newell, T. Lin, E. Ritchie, S. Strickland, et al. “CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS.” In HAEMATOLOGICA, 101:186–186. FERRATA STORTI FOUNDATION, 2016.
Lancet J, Uy G, Cortes J, Newell L, Lin T, Ritchie E, et al. CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2016. p. 186–186.
Lancet J, Uy G, Cortes J, Newell L, Lin T, Ritchie E, Strickland S, Stuart R, Hogge D, Solomon S, Stone R, Bixby D, Kolitz J, Schiller G, Wieduwilt M, Rao A, Rubenstein S, Stock W, Foster M, Erba H, Goldberg S, Powell B, Podoltsev N, Atallah E, Warlick E, Yee K, Pagel J, Norkin M, Barta S, Sandhu I, Frankfurt O, Gautier M, Larson M, Seiter K, Levy M, Bergeron J, Berdeja J, Kropf P, Shemanski L, Ryan D, Chiarella M, Paulsen K, Louie A, Medeiros B. CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2016. p. 186–186.

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 1, 2016

Volume

101

Start / End Page

186 / 186

Location

Copenhagen, DENMARK

Publisher

FERRATA STORTI FOUNDATION

Conference Name

21st Congress of the European-Hematology-Association

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology